Clinical Trial Update: Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing FEIBA to Fresh Frozen Plasma as first-line treatment for bleeding after cardiac surgery, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Disease
• Postoperative Hemorrhage

Drugs mentioned

• FEIBA (activated prothrombin complex concentrate)
• Fresh Frozen Plasma (fresh frozen plasma)

Snippet

Sponsor: Northwell Health | Conditions: Cardiac Disease, Surgery | Phase 2 | Status: RECRUITING